Drug Database · Clinicians

Bromazepam

Brands (1) LexotanShow all

Anxiolytic PH FDA category

S2 · Dangerous drug — PDEA S2 license required; see prescription rules belowRx · Prescription drug1 PH productPNF-listedVAT-exempt

1971 Convention Schedule IV; Philippine Schedule 4; PDEA S-2 license required. Oral FDA-registered Philippine Schedule 4 preparations: ordinary prescription in triplicate (BR 1 s.2014 Sec. 4(4)(a)); other forms: DOH Special Prescription Form (yellow) (Sec. 31(2)). No refill; up to a 30-day supply, 60 days for epilepsy and dystonia (Sec. 31(6)(d)-(e)). Until June 30, 2027, S-2 licensed practitioners may use an ordinary prescription in triplicate instead of the special form (one dangerous drug per prescription, "NO REFILL", up to 30 days; 60 days for Philippine Schedule 4 drugs in epilepsy and dystonia) (BR 10 s.2025, extended by BR 5 s.2026). Source: DDB, Updated Lists of Scheduled Controlled Substances (as of 20 July 2026); Republic Act No. 9165, Comprehensive Dangerous Drugs Act of 2002; DDB Board Regulation No. 3, s. 2020 (CBD drug products; defines Philippine Schedules 1-4); DDB Board Regulation No. 1, s. 2014 (amending BR 3 s. 2003: licensing, prescriptions, exemptions); DDB Board Regulation No. 10, s. 2025 (temporary authorization of ordinary prescriptions for dangerous drugs); DDB Board Regulation No. 5, s. 2026 (ordinary prescriptions for dangerous drugs extended to June 30, 2027).

Dispensing: Prescription (Rx) · Dangerous drug (S2) Last updated: Audience: Licensed health professionals

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Tablet: 1.5 mg

Registered products in the Philippines

1 product registered with the Food and Drug Administration (FDA) Philippines list Bromazepam as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Bromazepam
Package insert
LexotanBromazepam
1.5 mg TabletClear PVC/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Delpharm Milano S.R.L.Italy
Zuellig Pharma Corporation
DR-XY40440
Dec 22, 2031

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Formulary and coverage

Philippine National FormularyListed as Bromazepam
PNF listingOral: 1.5 mg tabletRestrictions: Dangerous drug: DOH Official Prescription Form (yellow Rx), S2 license, no refill (PNF code A1)
PhilHealth GAMOTNo

Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  2. PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .